Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
Public ClinicalTrials.gov record NCT03828019. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT03828019
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- JHSPH Center for Clinical Trials
- Other
- Enrollment
- 227 participants
Conditions and interventions
Conditions
Interventions
- Adalimumab (ADA) Biological
- Conventional immunosuppression (CON) Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 13 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 15, 2019
- Primary completion
- Apr 1, 2024
- Completion
- Sep 8, 2024
- Last update posted
- May 15, 2025
2019 – 2024
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Jules Stein Eye Institute, UCLA | Los Angeles | California | 90095 | — |
| University of California, San Francisco | San Francisco | California | 94143 | — |
| Anne Bates Leach Eye Hospital, University of Miami Miller School of Medicine | Miami | Florida | 33136 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| Johns Hopkins University | Baltimore | Maryland | 21287 | — |
| National Eye Institute | Bethesda | Maryland | 20892 | — |
| Ophthalmic Consultants of Boston | Boston | Massachusetts | 02114 | — |
| University of Michigan Health System, Kellogg Eye Center | Ann Arbor | Michigan | 48105 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| MidAtlantic Retina, Wills Eye Hospital | Philadelphia | Pennsylvania | 19107 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
| Tennessee Retina | Nashville | Tennessee | 37203 | — |
| Vanderbilt University Eye Institute | Nashville | Tennessee | 37232 | — |
| Retinal Consultants of Texas | Bellaire | Texas | 77401 | — |
| University of Utah, Moran Eye Center | Salt Lake City | Utah | 84132 | — |
| University of Washington, Medicine Eye Institute | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03828019, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 15, 2025 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03828019 live on ClinicalTrials.gov.